Modified phosphatidylserine-dependent antiprothrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies

Articles in the same Issue

1. Editorial
2. Athlete's biological passport: to test or not to test?
3. Review
4. Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target
5. Opinion Papers
6. The function of oxalic acid in the human metabolism
7. Current limitations of the Athlete's Biological Passport use in sports
8. Limits and pitfalls of Athlete's Biological Passport
9. The Athlete Biological Passport from the perspective of an anti-doping organization
10. Perspectives
11. Genetics of infectious diseases: hidden etiologies and common pathways
12. Guidelines and Recommendations
13. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 °C. Part 9: Reference procedure for the measurement of catalytic concentration of alkaline phosphatase
14. Genetics and Molecular Diagnostics
15. A template for mutational data analysis of the CFTR gene
16. High resolution melting analysis to genotype the most common variants in the HFE gene
17. General Clinical Chemistry and Laboratory Medicine
18. Bayesian analysis of an international ELISA comparability study
19. Inflammatory markers in preeclamptic patients
20. Pre-analytical effects of different lithium heparin plasma separation tubes in the routine clinical chemistry laboratory
21. Pre-acquisition system assessment of the Sysmex^® Coagulation System CS-2100i and comparison with end-user verification; a model for the regional introduction of new analysers and methods
22. Evaluation of a commercially available rapid urinary porphobilinogen test
23. Reference Values and Biological Variations
24. Reference intervals and age and gender dependency for arterial blood gases and electrolytes in adults
25. Within-subject biological variation of glucose and HbA_1c in healthy persons and in type 1 diabetes patients
26. Determinants of oxidative stress related to gender: relevance of age and smoking habit
27. Soluble ST2 is not independently associated with androgen and estrogen status in healthy males and females
28. Infectious Diseases
29. Development of candidate reference reagent for HIV-1 RNA and comparison analysis for different HIV-1 RNA quantitative assay
30. Prognostic value of serum angiotensin-converting enzyme activity for outcome of community-acquired pneumonia
31. The evaluation of colloidal gold immunochromatographic assay (GICA) for rapid diagnosis of influenza A disease
32. Cardiovascular Disease
33. N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity
34. Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris
35. Prospective study of first stroke in relation to plasma homocysteine and MTHFR 677C>T and 1298A>C genotypes and haplotypes – evidence for an association with hemorrhagic stroke
36. Letters to the Editor
37. Evaluation of the analytical performance of the Beckman Coulter AU680 automated analytical system based on quality specifications for allowable performance derived from biological variation
38. Collagen peptides, interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy
39. Erratum
40. Modified phosphatidylserine-dependent antiprothrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies